The content on this site is intended for healthcare professionals only
Prof Schilsky speaks with ecancer about the overarching mission of the WIN consortium.
He begins by outlining the successes so far coming out of the WIN consortium since its conception, including the WIN consortiums and WIN's clinical trials.
He moves on to a description of this year's 2019 WIN symposium, including key speakers, themes, and goals.
Finally, Dr Schilsky explains the future goals of WIN, including the implementation of global precision oncology.
ESMO 2024: Best practice in HRRm testing in patients with metastatic prostate cancer
Multiple myeloma In Rwanda: The need for further research
Addressing the rise of multiple myeloma in Rwanda
ELCC 2024: Latest in EGFR mutant lung cancer; exon 20 mutation focus
Choosing Wisely in radiology Tanzania
The advantages of IORT for early breast cancer treatment
Neo-adjuvant therapy for different cancers in the Philippines
SOFT study: Clinical relevance of genomic alterations in premenopausal HR+, HER2- early breast cancer
Moving to the future: Artificial intelligence in surgery
